Acute limb ischemia (ALI) is a medical emergency that can be due to prolonged tourniquet application, peripheral arterial disease, arterial embolization, and/or arterial thrombosis. To prevent associated morbidity and mortality, ischemia time should be minimized by urgent or emergent revascularization. However, revascularization can lead to ischemia-reperfusion injury (IRI), a devastating complication that can cause limb loss, multi-organ failure, and/or death. Currently, management of IRI largely relies on preventative measures and supportive care. In Part 2 of this two-part review article, we will briefly review the pathophysiology of IRI discussed in Part 1, and then discuss contemporary interventions to perfuse an acutely ischemic limb, clinical strategies that have been used to reduce and/or prevent IRI, and lastly, randomized controlled trials that have investigated pharmacological interventions to neutralize or mitigate IRI toxicity.
BarilDTGhoshKRosenAB. Trends in the incidence, treatment, and outcomes of acute lower extremity ischemia in the United States Medicare population. J Vasc Surg. 2014;60(3):669. doi:10.1016/j.jvs.2014.03.244
2.
ObaraHMatsubaraKKitagawaY. Acute limb ischemia. Ann Vasc Dis. 2018;11(4):443-448. doi:10.3400/avd.ra.18-00074
3.
MathruMDriesDJBarnesLToninoPSukhaniRRooneyMW. Tourniquet-induced exsanguination in patients requiring lower limb surgery. An ischemia-reperfusion model of oxidant and antioxidant metabolism. Anesthesiology. 1996;84(1):14-22. doi:10.1097/00000542-199601000-00003
4.
XuYXuWWangA, et al.Diagnosis and treatment of traumatic vascular injury of limbs in military and emergency medicine: a systematic review. Medicine (Baltim). 2019;98(18):e15406. doi:10.1097/MD.0000000000015406
5.
LiangZZhangWZhuT, et al.Ischemia-reperfusion injury in peripheral artery disease and traditional Chinese medicine treatment. Evid Based Complement Alternat Med. 2021;2021:4954070. doi:10.1155/2021/4954070
6.
CowledPFitridgeR. Pathophysiology of reperfusion injury. In: FitridgeRThompsonM, eds. Mechanisms of Vascular Disease: A Reference Book for Vascular Specialists. 2011.
7.
WatsonJDGiffordSMClouseWD. Biochemical markers of acute limb ischemia, rhabdomyolysis, and impact on limb salvage. Semin Vasc Surg. 2014;27(3-4):176-181. doi:10.1053/j.semvascsurg.2015.01.007
8.
EliasonJLWakefieldTW. Metabolic consequences of acute limb ischemia and their clinical implications. Semin Vasc Surg. 2009;22(1):29-33. doi:10.1053/j.semvascsurg.2009.01.001
9.
SzijartoATurocziZSzaboJ, et al.Rapidly progressing fatal reperfusion syndrome caused by acute critical ischemia of the lower limb. Cardiovasc Pathol. 2013;22(6):493-500. doi:10.1016/j.carpath.2013.02.006
10.
ZhangMLiuQMengH, et al.Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Signal Transduct Targeted Ther. 2024;9(1):12. doi:10.1038/s41392-023-01688-x
11.
ValleJAWaldoSW. Current endovascular management of acute limb ischemia. Interv Cardiol Clin. 2017;6(2):189-196. doi:10.1016/j.iccl.2016.12.003
12.
BjorckMEarnshawJJAcostaS, et al.Editor's choice - European society for vascular surgery (ESVS) 2020 clinical practice guidelines on the management of acute limb ischaemia. Eur J Vasc Endovasc Surg. 2020;59(2):173-218. doi:10.1016/j.ejvs.2019.09.006
13.
RutherfordRBBakerJDErnstC, et al.Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(3):517-538. doi:10.1016/s0741-5214(97)70045-4
14.
SlamaRVillaumeF. Penetrating vascular injury: diagnosis and management updates. Emerg Med Clin. 2017;35(4):789-801. doi:10.1016/j.emc.2017.06.005
15.
DayanLZinmannCStahlSNormanD. Complications associated with prolonged tourniquet application on the battlefield. Mil Med. 2008;173(1):63-66. doi:10.7205/milmed.173.1.63
16.
Sabate-FerrisAPfisterGBoddaertG, et al.Prolonged tactical tourniquet application for extremity combat injuries during war against terrorism in the Sahelian strip. Eur J Trauma Emerg Surg. 2022;48(5):3847-3854. doi:10.1007/s00068-021-01828-4
17.
BenItezCYOttolinoPPereiraBM, et al.Tourniquet use for civilian extremity hemorrhage: systematic review of the literature. Rev Col Bras Cir. 2021;48:e20202783. doi:10.1590/0100-6991e-20202783
18.
HenryRMatsushimaKGhafilC, et al.Increased use of prehospital tourniquet and patient survival: los Angeles countywide study. J Am Coll Surg. 2021;233(2):233-239. doi:10.1016/j.jamcollsurg.2021.03.023
KingEGFarberA. What is the best treatment for acute limb ischemia?Adv Surg. 2022;56(1):287-304. doi:10.1016/j.yasu.2022.03.004
21.
ForsythAHaqqaniMHAlfsonDB, et al.Long-term outcomes of autologous vein bypass for repair of upper and lower extremity major arterial trauma. J Vasc Surg. 2024;79(6):1339-1346. doi:10.1016/j.jvs.2024.01.204
22.
Marques de MarinoPMartinez LopezIRevuelta SueroS, et al.Results of infrainguinal bypass in acute limb ischaemia. Eur J Vasc Endovasc Surg. 2016;51(6):824-830. doi:10.1016/j.ejvs.2016.03.023
23.
VertreesAFoxCJQuanRWCoxMWAdamsEDGillespieDL. The use of prosthetic grafts in complex military vascular trauma: a limb salvage strategy for patients with severely limited autologous conduit. J Trauma. 2009;66(4):980-983. doi:10.1097/TA.0b013e31819c59ac
24.
Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg. 1994;220(3):251-266. doi:10.1097/00000658-199409000-00003
25.
OurielKVeithFJSasaharaAA. Thrombolysis or peripheral arterial surgery: phase I results. TOPAS investigators. J Vasc Surg. 1996;23(1):64-73. doi:10.1016/s0741-5214(05)80036-9
26.
GongMHeXZhaoBKongJGuJChenG. Endovascular revascularization strategies using catheter-based thrombectomy versus conventional catheter-directed thrombolysis for acute limb ischemia. Thromb J. 2021;19(1):96. doi:10.1186/s12959-021-00349-9
27.
TheodoridisPGDavosCHDodosI, et al.Thrombolysis in acute lower limb ischemia: review of the current literature. Ann Vasc Surg. 2018;52:255-262. doi:10.1016/j.avsg.2018.02.030
28.
MolBMVerwerMCFijnheerR, et al.Predictors of bleeding complications during catHeter-dirEcted thrombolysis for peripheral arterial occlusions (POCHET). PLoS One. 2024;19(5):e0302830. doi:10.1371/journal.pone.0302830
29.
WangJCKimAHKashyapVS. Open surgical or endovascular revascularization for acute limb ischemia. J Vasc Surg. 2016;63(1):270-278. doi:10.1016/j.jvs.2015.09.055
30.
HardigBMPerssonHWOlssonSB. Low-energy ultrasound exposure of the streptokinase molecule may enhance but also attenuate its fibrinolytic properties. Thromb Res. 2006;117(6):713-720. doi:10.1016/j.thromres.2005.05.027
31.
SchrijverAMvan LeersumMFiooleB, et al.Dutch randomized trial comparing standard catheter-directed thrombolysis and ultrasound-accelerated thrombolysis for arterial thromboembolic infrainguinal disease (DUET). J Endovasc Ther. 2015;22(1):87-95. doi:10.1177/1526602814566578
32.
WissgottCRichterAKamusellaPSteinkampHJ. Treatment of critical limb ischemia using ultrasound-enhanced thrombolysis (PARES trial): final results. J Endovasc Ther. 2007;14(4):438-443. doi:10.1177/152660280701400402
33.
AraujoSTMorenoDHCacioneDG. Percutaneous thrombectomy or ultrasound-accelerated thrombolysis for initial management of acute limb ischaemia. Cochrane Database Syst Rev. 2022;1(1):CD013486. doi:10.1002/14651858.CD013486.pub2
34.
ChaitJAurshinaAMarksNHingoraniAAscherE. Comparison of ultrasound-accelerated versus multi-hole infusion catheter-directed thrombolysis for the treatment of acute limb ischemia. Vasc Endovasc Surg. 2019;53(7):558-562. doi:10.1177/1538574419861768
35.
GeorgeELColvardBHoVTRothenbergKALeeJTSternJR. Real-world outcomes of EKOS ultrasound-enhanced catheter-directed thrombolysis for acute limb ischemia. Ann Vasc Surg. 2020;66:479-485. doi:10.1016/j.avsg.2019.12.026
36.
LindBMorcosOFerralH, et al.Endovascular strategies in the management of acute limb ischemia. Vasc Specialist Int. 2019;35(1):4-9. doi:10.5758/vsi.2019.35.1.4
37.
LoffroyRFalvoNGallandC, et al.Percutaneous rotational mechanical atherectomy plus thrombectomy using Rotarex S device in patients with acute and subacute lower Limb ischemia: a review of safety, efficacy, and outcomes. Front Cardiovasc Med. 2020;7:557420. doi:10.3389/fcvm.2020.557420
38.
AudaMERatnerMPezoldM, et al.Short-term outcomes of endovascular management of acute limb ischemia using aspiration mechanical thrombectomy. Vascular. 2024;33:34-41. doi:10.1177/17085381241236923
39.
BathJKimRJDombrovskiyVYVogelTR. Contemporary trends and outcomes of thrombolytic therapy for acute lower extremity ischemia. Vascular. 2019;27(1):71-77. doi:10.1177/1708538118797782
40.
de Athayde SoaresRMatieloMFBrochado NetoFC, et al.Analysis of the results of endovascular and open surgical treatment of acute limb ischemia. J Vasc Surg. 2019;69(3):843-849. doi:10.1016/j.jvs.2018.07.056
41.
de Athayde SoaresRMatieloMFBrochado NetoFCPereira de CarvalhoBVSacilottoR. Analysis of the safety and efficacy of the endovascular treatment for acute limb ischemia with percutaneous pharmacomechanical thrombectomy compared with catheter-directed thrombolysis. Ann Vasc Surg. 2020;66:470-478. doi:10.1016/j.avsg.2019.11.038
42.
HolscherCMCannerJKGaronzik WangJMAbularrageCJBlackJH3rdHicksCW. Temporal trends and hospital costs associated with an endovascular-first approach for acute limb ischemia. J Vasc Surg. 2019;70(5):1506-1513. doi:10.1016/j.jvs.2019.01.062
43.
PoursinaOElizondo-AdamchikHMontero-BakerMPallisterZSMillsJLChungJ. Safety and efficacy of an endovascular-first approach to acute limb ischemia. J Vasc Surg. 2021;73(5):1741-1749. doi:10.1016/j.jvs.2020.10.002
44.
JarosinskiMKennedyJNKhamzinaY, et al.Percutaneous thrombectomy for acute limb ischemia is associated with equivalent limb and mortality outcomes compared with open thrombectomy. J Vasc Surg. 2024;79(5):1151-1162. doi:10.1016/j.jvs.2024.01.014
45.
PercivalTJRasmussenTE. Reperfusion strategies in the management of extremity vascular injury with ischaemia. Br J Surg. 2012;99(Suppl 1):66-74. doi:10.1002/bjs.7790
46.
PapalambrosELPanayiotopoulosYPBastounisEZavosGBalasP. Prophylactic fasciotomy of the legs following acute arterial occlusion procedures. Int Angiol. 1989;8(3):120-124.
47.
BurkhardtGEGiffordSMPropperB, et al.The impact of ischemic intervals on neuromuscular recovery in a porcine (Sus scrofa) survival model of extremity vascular injury. J Vasc Surg. 2011;53(1):165-173. doi:10.1016/j.jvs.2010.07.012
48.
BurkhardtGESpencerJRGiffordSM, et al.A large animal survival model (Sus scrofa) of extremity ischemia/reperfusion and neuromuscular outcomes assessment: a pilot study. J Trauma. 2010;69(Suppl 1):S146-S153. doi:10.1097/TA.0b013e3181e6a09b
49.
HancockHMStannardABurkhardtGE, et al.Hemorrhagic shock worsens neuromuscular recovery in a porcine model of hind limb vascular injury and ischemia-reperfusion. J Vasc Surg. 2011;53(4):1052-1062. doi:10.1016/j.jvs.2010.10.104
50.
AlarhayemAQCohnSMCantu-NunezOEastridgeBJRasmussenTE. Impact of time to repair on outcomes in patients with lower extremity arterial injuries. J Vasc Surg. 2019;69(5):1519-1523. doi:10.1016/j.jvs.2018.07.075
51.
GiffordSMAidinianGClouseWD, et al.Effect of temporary shunting on extremity vascular injury: an outcome analysis from the global war on terror vascular injury initiative. J Vasc Surg. 2009;50(3):549-555. doi:10.1016/j.jvs.2009.03.051
52.
TallerJKamdarJPGreeneJA, et al.Temporary vascular shunts as initial treatment of proximal extremity vascular injuries during combat operations: the new standard of care at Echelon II facilities?J Trauma. 2008;65(3):595-603. doi:10.1097/TA.0b013e31818234aa
53.
WoodwardEBClouseWDEliasonJL, et al.Penetrating femoropopliteal injury during modern warfare: experience of the balad vascular registry. J Vasc Surg. 2008;47(6):1259-1264. doi:10.1016/j.jvs.2008.01.052
54.
HornezEBoddaertGNgabouUD, et al.Temporary vascular shunt for damage control of extremity vascular injury: a toolbox for trauma surgeons. J Vis Surg. 2015;152(6):363-368. doi:10.1016/j.jviscsurg.2015.09.005
55.
MartinelliOMiceliFCuozzoS, et al.Temporary intravascular shunts and limb salvage in civilian vascular trauma. Front Surg. 2023;10:1302976. doi:10.3389/fsurg.2023.1302976
56.
IzawaYFutamuraKMurakamiH, et al.Cross-limb vascular shunting for traumatic popliteal artery injury. Ann Vasc Surg. 2024;99:305-311. doi:10.1016/j.avsg.2023.08.033
OrrapinSOrrapinSArwonSRerkasemK. Predictive factors for post-ischemic compartment syndrome in non-traumatic acute limb ischemia in a lower extremity. Ann Vasc Dis. 2017;10(4):378-385. doi:10.3400/avd.oa.17-00055
59.
VakhitovDMellaMHakovirtaH, et al.Prognostic risk factors for the development of compartment syndrome in acute lower limb ischemia patients treated with catheter-directed thrombolysis. Ann Vasc Surg. 2022;84:305-313. doi:10.1016/j.avsg.2022.01.008
60.
AllenBSBuckbergGDFontanFM, et al.Superiority of controlled surgical reperfusion versus percutaneous transluminal coronary angioplasty in acute coronary occlusion. J Thorac Cardiovasc Surg. 1993;105(5):864-879.
61.
WilhelmMPSchlensakCHohA, et al.Controlled reperfusion using a simplified perfusion system preserves function after acute and persistent limb ischemia: a preliminary study. J Vasc Surg. 2005;42(4):690-694. doi:10.1016/j.jvs.2005.05.055
62.
AllenBSHartzRSBuckbergGDSchulerJJ. Prevention of ischemic damage using controlled limb reperfusion. J Card Surg. 1998;13(3):224-227. doi:10.1111/j.1540-8191.1998.tb01266.x
63.
HeilmannCSchmoorCSiepeM, et al.Controlled reperfusion versus conventional treatment of the acutely ischemic limb: results of a randomized, open-label, multicenter trial. Circ Cardiovasc Interv. 2013;6(4):417-427. doi:10.1161/CIRCINTERVENTIONS.112.000371
64.
SchmidtCARancicZLachatMLMayerDOVeithFJWilhelmMJ. Hypothermic, initially oxygen-free, controlled limb reperfusion for acute limb ischemia. Ann Vasc Surg. 2015;29(3):560-572. doi:10.1016/j.avsg.2014.09.033
65.
ChananELBinghamNSmithDENunnallyME. Early detection, prevention, and management of acute limb ischemia in adults supported with venoarterial extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth. 2020;34(11):3125-3132. doi:10.1053/j.jvca.2020.02.020
66.
CoteDRFuentesEElsayesAHRossJJQuraishiSA. A “crush” course on rhabdomyolysis: risk stratification and clinical management update for the perioperative clinician. J Anesth. 2020;34(4):585-598. doi:10.1007/s00540-020-02792-w
67.
ScharmanEJTroutmanWG. Prevention of kidney injury following rhabdomyolysis: a systematic review. Ann Pharmacother. 2013;47(1):90-105. doi:10.1345/aph.1R215
68.
BrownCVRheePChanLEvansKDemetriadesDVelmahosGC. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?J Trauma. 2004;56(6):1191-1196. doi:10.1097/01.ta.0000130761.78627.10
69.
HomsiEBarreiroMFOrlandoJMHigaEM. Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail. 1997;19(2):283-288. doi:10.3109/08860229709026290
70.
NielsenJSSallyMMullinsRJ, et al.Bicarbonate and mannitol treatment for traumatic rhabdomyolysis revisited. Am J Surg. 2017;213(1):73-79. doi:10.1016/j.amjsurg.2016.03.017
71.
ErturkMCakmakHASurgitO, et al.Predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease. J Cardiol. 2014;64(5):371-376. doi:10.1016/j.jjcc.2014.02.019
72.
KordzadehAMalietzisGBrowneTPrionidisIPanayiotopoulosYP. Neutrophil to lymphocyte ratio (NLR) of five predicts 30-day morbidity in ruptured abdominal aortic aneurysms (rAAA): a retrospective cohort study. Int J Surg. 2015;15:45-48. doi:10.1016/j.ijsu.2015.01.013
73.
TasogluICicekOFLafciG, et al.Usefulness of neutrophil/lymphocyte ratio as a predictor of amputation after embolectomy for acute limb ischemia. Ann Vasc Surg. 2014;28(3):606-613. doi:10.1016/j.avsg.2012.12.009
74.
TaurinoMAloisiFDel PortoF, et al.Neutrophil-to-Lymphocyte ratio could predict outcome in patients presenting with acute limb ischemia. J Clin Med. 2021;10(19):4343. doi:10.3390/jcm10194343
75.
PekerKOkesliSKiyiciADeyisliC. The effects of ketamine and lidocaine on free radical production after tourniquet-induced ischemia-reperfusion injury in adults. Ulus Travma Acil Cerrahi Derg. 2019;25(2):111-117. doi:10.5505/tjtes.2018.63439
76.
SaricaogluFDalDSalmanAEDoralMNKlncKAyparU. Ketamine sedation during spinal anesthesia for arthroscopic knee surgery reduced the ischemia-reperfusion injury markers. Anesth Analg. 2005;101(3):904-909. doi:10.1213/01.ANE.0000159377.15687.87
77.
WangLWangWZhaoX, et al.Effect of Shenmai injection, a traditional Chinese medicine, on pulmonary dysfunction after tourniquet-induced limb ischemia-reperfusion. J Trauma. 2011;71(4):893-897. doi:10.1097/TA.0b013e318205e279
78.
AndreasMSchmidAIDobererD, et al.Heme arginate improves reperfusion patterns after ischemia: a randomized, placebo-controlled trial in healthy male subjects. J Cardiovasc Magn Reson. 2012;14(1):55. doi:10.1186/1532-429X-14-55
79.
ChengWWangMLiuPZhaoSLiuXWangX. Protective effects of dexmedetomidine and oxycodone in patients undergoing limb ischemia-reperfusion. Med Sci Monit. 2019;25:9073-9084. doi:10.12659/MSM.918261
80.
PinarHUPinarAMaviogluOYenerN. Effect of hydroxyethyl starch 130/0.4 on ischemia-reperfusion determinants in minor lower extremity surgery with tourniquet application. J Clin Anesth. 2015;27(2):105-110. doi:10.1016/j.jclinane.2014.07.001
81.
TuranRYagmurdurHKavutcuMDikmenB. Propofol and tourniquet induced ischaemia reperfusion injury in lower extremity operations. Eur J Anaesthesiol. 2007;24(2):185-189. doi:10.1017/S0265021506001347
82.
TurchanyiBKoreiCSomogyiVKissFPetoKNemethN. Beneficial postoperative micro-rheological effects of intraoperative administration of diclophenac or ischemic preconditioning in patients with lower extremity operations - preliminary data. Clin Hemorheol Microcirc. 2021;79(4):557-565. doi:10.3233/CH-211200
83.
HallstromLFrostellCHerrlinALindroosELundbergISoopA. No signs of inflammation during knee surgery with ischemia: a study involving inhaled nitric oxide. Mediat Inflamm. 2014;2014:620281. doi:10.1155/2014/620281
84.
JouybarRKhademiSRazmjooieSBagheriN. Effect of preoperative administration of oral melatonin on pneumatic tourniquet-induced ischemia-reperfusion injury in orthopedic surgery of lower extremities: a randomized clinical trial. Iran J Med Sci. 2022;47(2):123-130. doi:10.30476/ijms.2021.86960.1701
85.
PiechockiMPrzewlockiTPieniazekPTrystulaMPodolecJKablak-ZiembickaNon-CoronaryAA. Peripheral arterial atherosclerotic disease (carotid, renal, lower limb) in elderly patients-A review PART II-pharmacological approach for management of elderly patients with peripheral atherosclerotic lesions outside coronary territory. J Clin Med. 2024;13(5):1508. doi:10.3390/jcm13051508
86.
GoCCAnnieFDrabishKEslamiMH. Glucagon-like peptide-1 receptor agonists are associated with fewer major adverse cardiovascular and limb events in patients with moderate peripheral arterial disease. J Vasc Surg. 2025;82(3):1024-1032. doi:10.1016/j.jvs.2025.05.037
87.
WiviottSDRazIBonacaMP, et al.Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380(4):347-357. doi:10.1056/NEJMoa1812389
88.
ChangCCChenYTHsuCY, et al.Dipeptidyl Peptidase-4 inhibitors, peripheral arterial disease, and lower extremity amputation risk in diabetic patients. Am J Med. 2017;130(3):348-355. doi:10.1016/j.amjmed.2016.10.016
89.
NennaANappiFLarobinaDVerghiEChelloMAmbrosioL. Polymers and nanoparticles for statin delivery: current use and future perspectives in cardiovascular disease. Polymers. 2021;13(5):711. doi:10.3390/polym13050711
90.
NagaokaKMatobaTMaoY, et al.A new therapeutic modality for acute myocardial infarction: nanoparticle-mediated delivery of pitavastatin induces cardioprotection from ischemia-reperfusion injury via activation of PI3K/Akt pathway and anti-inflammation in a rat model. PLoS One. 2015;10(7):e0132451. doi:10.1371/journal.pone.0132451
91.
MatsumotoTYoshinoSFuruyamaT, et al.Pitavastatin-incorporated nanoparticles for chronic limb threatening ischemia: a phase I/IIa clinical trial. J Atherosclerosis Thromb. 2022;29(5):731-746. doi:10.5551/jat.58941
92.
RowartPErpicumPDetryO, et al.Mesenchymal stromal cell therapy in ischemia/reperfusion injury. J Immunol Res. 2015;2015:602597. doi:10.1155/2015/602597
93.
HeldmanAWDiFedeDLFishmanJE, et al.Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA. 2014;311(1):62-73. doi:10.1001/jama.2013.282909
